TORSO

• Research type

  Research Study

• Full title

  Tablet OR Suspension Of posaconazole study (TORSO study)

• IRAS ID

  182485

• Contact name

  Harpal Lamba

• Contact email

  harpal.lamba@merck.com

• Sponsor organisation

  Merck Sharpe and Dohme

• Duration of Study in the UK

  0 years, 9 months, days

• Research summary

  This study is using questionnaires to find out whether patients express a preference for the solid oral tablet or the oral suspension of posaconazole (Noxafil)

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  15/EM/0367

• Date of REC Opinion

  10 Aug 2015

• REC opinion

  Favourable Opinion